Sign In
Last checked at 
6 Apr 2018 14:40
Physiomics plc
("Physiomics") or ("the Company")
Director Dealing
The Company announces that it received notice today that Dr Chassagnole (COO) transferred paper share certificates of 121,522 shares and 265,111 shares to his nominee account 'Interactive Investor Services Nominees Limited'.
Following the transfer of shares, Dr Chassagnole's beneficial holding remains unchanged at 417,008 ordinary shares (equivalent to 0.71% of the currently issued share capital).
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Christophe Chassagnole | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director, COO | ||||
b) | Initial notification/ Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Physiomics plc | ||||
b) | LEI | 213800A71DSZ6ABMTQ91 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Transfer of securities held in paper share certificates to nominee account 'Interactive Investor Services Nominees Limited'
GB00BDR6W943 | ||||
b) | Nature of the transaction | Trans | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
386,663 N/A | ||||
e) | Date of the transaction | 05/04/2018 | ||||
f) | Place of the transaction | XOFF | ||||
Enquiries:
Physiomics plc
Dr Jim Millen, CEO
+44 (0)1865 784 980
WH Ireland Limited (nomad)
Katy Mitchell, James Sinclair-Ford
+44 (0) 161 832 2174
Hybridan LLP (broker)
Claire Louise Noyce
+44 (0) 203 764 2341
The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.
Follow the stocks
